Processing

Please wait...

Settings

Settings

1. WO2020002314 - RADIOLABELED CANNABINOID RECEPTOR 2 LIGAND

Publication Number WO/2020/002314
Publication Date 02.01.2020
International Application No. PCT/EP2019/066799
International Filing Date 25.06.2019
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
51
Preparations containing radioactive substances for use in therapy or testing in vivo
02
characterised by the carrier
04
Organic compounds
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
58
involving labelled substances
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
401
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
02
containing two hetero rings
04
directly linked by a ring-member-to-ring- member bond
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
101
Radioactive non-metals
02
Halogens
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
B
GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
59
Introduction of isotopes of elements into organic compounds
A61K 51/04 (2006.01)
G01N 33/58 (2006.01)
C07D 401/04 (2006.01)
A61K 101/02 (2006.01)
C07B 59/00 (2006.01)
CPC
A61K 51/0455
A61K 51/0459
C07B 59/002
C07D 401/04
G01N 33/60
G01N 33/948
Applicants
  • F. HOFFMANN-LA ROCHE AG [CH/CH]; Grenzacherstrasse 124 4070 Basel, CH (AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BE, BF, BG, BH, BJ, BN, BR, BW, BY, BZ, CA, CF, CG, CH, CI, CL, CM, CN, CO, CR, CU, CY, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GQ, GR, GT, GW, HN, HR, HU, ID, IE, IL, IN, IR, IS, IT, JO, JP, KE, KG, KH, KM, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MC, MD, ME, MG, MK, ML, MN, MR, MT, MW, MX, MY, MZ, NA, NE, NG, NI, NL, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SI, SK, SL, SM, SN, ST, SV, SY, SZ, TD, TG, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, ZA, ZM, ZW)
  • HOFFMANN-LA ROCHE INC. [US/US]; Overlook at Great Notch, 150 Clove Road 8th Floor, Suite 8 - Legal Department Little Falls, New Jersey 07424, US (US)
  • ETH ZUERICH [CH/CH]; Raemistrasse 101 8092 Zuerich, CH
Inventors
  • AMETAMEY, Simon M.; CH
  • GOBBI, Luca; CH
  • GRETHER, Uwe; CH
  • KRETZ, Julian; CH
  • MURI, Dieter; CH
  • HAIDER WAHAUIB, Ahmed; CH
Agents
  • POMERANC, Didier; CH
Priority Data
18180154.927.06.2018EP
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) RADIOLABELED CANNABINOID RECEPTOR 2 LIGAND
(FR) LIGAND DU RÉCEPTEUR CANNABINOÏDE 2 RADIOMARQUÉ
Abstract
(EN)
The present invention relates to a compound of formula (I) wherein R1, R2, and R3 are defined as in the description and in the claims. The compound of formula (I) can be used as a radiolabeled ligand.
(FR)
La présente invention concerne un composé de formule (I) dans laquelle R1, R2 et R3 sont tels que définis dans la description et dans les revendications. Le composé de formule (I) peut être utilisé en tant que ligand radiomarqué.
Latest bibliographic data on file with the International Bureau